SCHEMBL15470629

SCHEMBL15470629

CC1(O)CN(C(=O)c2ccc(C(C)(C)C)cc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.61
KMT2A Q03164 7/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
ALDH1A1 P00352 2/20 0.61
HTT P42858 2/20 0.61
HPGD P15428 2/20 0.59
ALOX15 P16050 1/20 0.59
KDM4E B2RXH2 1/20 0.48
ABL1 P00519 1/20 0.47
BCR P11274 1/20 0.47
LMNA P02545 2/20 0.46
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MITF O75030 1/20 0.46
RAB9A P51151 1/20 0.45
HDAC1 Q13547 1/20 0.44
CNR1 P21554 2/20 0.44
CNR2 P34972 2/20 0.44
THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18216826 0.88 MEN1 (0.63) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL15470631 0.84 MEN1 (0.67) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL15470630 0.83 MEN1 (0.61) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL20625624 0.83 MEN1 (0.56) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL15617690 0.81 ACHE (0.49) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL15473394 0.81 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDLMNA
SCHEMBL26424718 0.81 MEN1 (0.62) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL17886683 0.81 MEN1 (0.58) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL19226561 0.80 HPGD (0.60) MEN1KMT2ASMN1; SMN2ALDH1A1HTT
SCHEMBL15317729 0.80 MEN1 (0.56) MEN1KMT2ASMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160326125-A1 SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2016-11-10 US disclosed
US-8987314-B2 Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-24 US disclosed
US-20140045811-A1 AMIDE, UREA OR SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045811-A1 AMIDE, UREA OR SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, LIPE, CEL MEN1 4822/4885KMT2A 1708/4885SMN1; SMN2 4524/4885
US-20160326125-A1 SULFONE AMIDE LINKED BENZOTHIAZOLE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, LIPE, LPL MEN1 4754/4885KMT2A 1836/4885SMN1; SMN2 4515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.